FrancophonIA/ELRC3.0 huggingface dataset:
English: Sometimes, a slight increase in the rectal temperature might occur after vaccination.
Slovenian: Občasno se lahko po cepljenju prehodno rahlo poviša rektalna temperatura.
English: EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR) RESPIPORC FLU3 EPAR summary for the public
Slovenian: EMEA/V/C/153 EVROPSKO JAVNO POROČILO O OCENI ZDRAVILA (EPAR) RESPIPORC FLU3 Povzetek EPAR za javnost
English: Other information about RESPIPORC FLU3:
Slovenian: Druge informacije o zdravilu RESPIPORC FLU3:
English: RESPIPORC FLU3 is a vaccine.
Slovenian: RESPIPORC FLU3 je cepivo.
English: RESPIPORC FLU3 is a vaccine that contains 3 different strains of swine influenza A virus which have been inactivated (killed).
Slovenian: RESPIPORC FLU3 je cepivo, ki vsebuje tri različne seve virusa prašičje gripe A, ki so bili inaktivirani (uničeni).
English: RESPIPORC FLU3 is a suspension for injection.
Slovenian: Zdravilo RESPIPORC FLU3 je suspenzija za injiciranje.
English: In the future, the immune system will be able to produce antibodies more quickly when it is again exposed to the viruses.
Slovenian: Ob ponovni izpostavitvi virusom v prihodnosti bo imunski sistem tako hitreje tvoril protitelesa.
English: RESPIPORC FLU3 is also used to vaccinate pregnant sows following their first immunisation by giving them one dose 14 days prior to farrowing in order that the sows milk contains enough antibodies to help protect the piglets against swine influenza for at least 33 days after birth.
Slovenian: Zdravilo RESPIPORC FLU3 se uporablja tudi za cepljenje brejih svinj po zaključeni prvi imunizaciji, z dajanjem enega odmerka 14 dni pred prasitvijo, da mleko svinj vsebuje dovolj protiteles, ki pujske ščitijo pred prašičjo gripo vsaj 33 dni po rojstvu.
English: What benefit has RESPIPORC FLU3 shown during the studies?
Slovenian: Kakšne koristi je zdravilo RESPIPORC FLU3 izkazalo med študijami?
English: RESPIPORC FLU3 contains small amounts of a modified and then killed form of the pig's influenza virus that causes lesions and illness.
Slovenian: Zdravilo RESPIPORC FLU3 vsebuje majhne količine modificirane in zatem inaktivirane oblike virusa prašičje gripe, ki povzroča lezije in bolezen.
English: Use of the RESPIPORC FLU3 in pigs reduces clinical signs and reduces the amount of virus in the lungs after infection caused by swine influenza A virus.
Slovenian: Uporaba cepiva RESPIPORC FLU3 pri prašičih zmanjša klinične znake in količino virusa v pljučih po okužbi, ki jo povzroči virus prašičje gripe A.
English: The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of RESPIPORC FLU3 exceed the risks for the vaccination of pigs from the age of 56 days onwards inluding pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection and recommended that RESPIPORC FLU3 be given a marketing authorisation.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je zaključil, da so koristi zdravila RESPIPORC FLU3 za cepljenje prašičev od 56 dneva starosti naprej, vključno z brejimi svinjami, proti prašičji gripi, ki jo povzročajo podtipi H1N1, H3N2 in H1N2, za zmanjšanje kliničnih znakov in prisotnosti virusa v pljučih po okužbi večje od z njim povezanih tveganj, in priporočil, da se za zdravilo RESPIPORC FLU3 odobri dovoljenje za promet.
English: The effectiveness of RESPIPORC FLU3 has been studied in animals 56 days of age and older and in sows before and during pregnancy and these studies document that the vaccine protects against swine influenza.
Slovenian: Učinkovitost zdravila RESPIPORC FLU3 so proučevali pri prašičih, starejših od 56 dni, in pri svinjah pred in med brejostjo, te študije pa dokazujejo, da cepivo zagotavlja zaščito pred prašičjo gripo.
English: A slight swelling may occur after vaccination at the site of injection in a small number of pigs but this goes down within 2 days.
Slovenian: Pri majhnem številu prašičev se lahko na mestu injiciranja pojavi manjša oteklina, ki običajno izgine v 2 dneh.
English: What is the risk associated with RESPIPORC FLU3?
Slovenian: Kakšna tveganja so povezana z zdravilom RESPIPORC FLU3?
English: Why has RESPIPORC FLU3 been approved?
Slovenian: Zakaj je bilo zdravilo RESPIPORC FLU3 odobreno?
English: RESPIPORC FLU3 is used to vaccinate pigs including pregnant sows over the age of 56 days against swine influenza in order to help them clinically but also to reduce the amount of virus present in the lungs.
Slovenian: Zdravilo RESPIPORC FLU3 se uporablja za cepljenje prašičev od 56 dneva starosti naprej, vključno z brejimi svinjami, proti prašičji gripi za zmanjšanje kliničnih znakov in prisotnosti virusa v pljučih.
English: What is RESPIPORC FLU3?
Slovenian: Kaj je zdravilo RESPIPORC FLU3?
English: How has RESPIPORC FLU3 been studied?
Slovenian: Kako je bilo zdravilo RESPIPORC FLU3 raziskano?
English: How does RESPIPORC FLU3 work?
Slovenian: Kako zdravilo RESPIPORC FLU3 deluje?
English: What is RESPIPORC FLU3 used for?
Slovenian: Za kaj se zdravilo RESPIPORC FLU3 uporablja?
English: ANNEX CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Slovenian: DODATEK POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO ZDRAVILA
English: Details of the operation of the surveillance programme/registry shall be agreed with the National Competent Authorities in each Member State.
Slovenian: O podrobnostih glede delovanja programa/registra nadzorovanja se je treba dogovoriti s pristojnimi državnimi organi v vsaki državi članici.
English: The data to be collected shall be agreed with the CHMP.
Slovenian: O zbiranju podatkov se je treba dogovoriti s CHMP.
English: • The need for regular pregnancy tests
Slovenian: • potrebno je redno izvajati teste nosečnosti
English: • That hormonal contraceptives on their own are not effective
Slovenian: • da samo hormonska kontracepcija ni učinkovita
English: The patient information booklet for patients prescribed Tracleer should include the following key elements:
Slovenian: Navodila za uporabo za bolnike, ki jim je predpisano zdravilo Tracleer, morajo vsebovati naslednje ključne elemente:
English: • Information about Tracleer
Slovenian: • podatke o zdravilu Tracleer
English: • That pregnant women must not take Tracleer
Slovenian: • da nosečnice ne smejo jemati zdravila Tracleer
English: The Member States shall ensure that the MAH shall set up a surveillance programme/registry to collect information on the demographics, safety and outcome data from patients prescribed Tracleer to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease.
Slovenian: Države članice zagotovijo, da IDIZ vzpostavi program/register nadzorovanja za zbiranje informacij o učinkih ter demografskih in varnostnih podatkih bolnikov, ki jim je bilo predpisano zdravilo Tracleer, da se zmanjša število novih razjed prstov pri bolnikih s sistemsko sklerozo ter dolgotrajno boleznijo razjed prstov.
English: • That women of child bearing potential must use effective contraception
Slovenian: • da morajo ženske v rodni dobi jemati učinkovito kontracepcijo
English: • That Tracleer is teratogenic in animals
Slovenian: • da je zdravilo Tracleer teratogeno za živali
English: The MAH shall agree the details of a controlled distribution system with the National Competent Authorities and must implement such programme nationally to ensure that prior to prescribing all health care professionals who intend to prescribe and/or dispense Tracleer are provided with a Prescriber Kit containing the following:
Slovenian: IDIZ se o podrobnostih nadzorovanega distribucijskega sistema dogovori s pristojnimi državnimi organi in mora tak program izvajati nacionalno in tako zagotovi, da imajo vsi strokovnjaki zdravstvenega varstva, ki nameravajo predpisati in/ali izdati zdravilo Tracleer, že pred predpisovanjem zagotovljeno opremo za predpisovanje, ki vsebuje:
English: • Patient Information Booklet/Patient Reminder Card
Slovenian: • navodilo za uporabo/kartico Opozorila za bolnika
English: • That Tracleer causes a decrease in haemoglobin and the need for regular blood tests
Slovenian: • da zdravilo Tracleer povzroča znižanje hemoglobina in je potrebno redno izvajati krvne analize
English: • That Tracleer is hepatotoxic and the need for regular monitoring of liver function
Slovenian: • da je zdravilo Tracleer hepatotoksično in je potrebno redno spremljati delovanje jeter
English: The MAH shall agree with each National Competent Authority the content of a "Reminder Letter" to all known prescribers of Tracleer, reminding them of the safety concerns with Tracleer in relation to pregnancy.
Slovenian: Imetnik dovoljenja za promet z zdravilom bo skupaj z nacionalnim pristojnim organom določil vsebino "Opomnika", s katerim bo vse zdravnike, za katere je znano, da predpisujejo zdravilo Tracleer, opomnil glede pomislekov v zvezi z varnostjo zdravila Tracleer med nosečnostjo.
English: 12 hours before your operation.
Slovenian: 12 ur po operaciji.
English: Operation or periods of limited mobility due to an illness
Slovenian: Ob operacijah ali obdobjih omejene mobilnosti zaradi bolezni
English: Do not use this medicine if you notice {description of the visible signs of deterioration}.
Slovenian: Tega zdravila ne uporabite, če opazite {opis vidnih znakov kvarjenja}.
English: • Benzyl alcohol
Slovenian: • Benzilalkohol
English: Pharmacotherapeutic group: Antithrombotic agent, heparin group, ATC code: B01A B05
Slovenian: Farmakoterapevtska skupina: antitrombotiki, heparinska skupina, oznaka ATC: B01A B05
English: (subcutaneous).
Slovenian: (subkutano).
English: This is a preservative.
Slovenian: To je konzervans.
English: swelling of your lips, face, throat or tongue.
Slovenian: oteklost ustnic, obraza, žrela ali jezika.
English: Do not use this medicine after the expiry date which is stated on the label.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pakiranju.
English: Detailed information on this medicinal product is available on the website of {name of MS Agency (link)}
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani {ime agencije DČ (povezava)}
English: This reduction in the combined incidence was maintained after 30 days (from 23.3 to 19.8%; relative risk reduction of
Slovenian: To zmanjšanje skupne incidence se je ohranilo po 30 dneh (s 23,3 na 19,8 %, relativno zmanjšanje tveganja 15 %).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: {DD month YYYY} Date of latest renewal: {DD month YYYY}
Slovenian: Datum prve odobritve: {DD. mesec LLLL} Datum zadnjega podaljšanja: {DD. mesec LLLL}
English: These medicinal products differ in their manufacturing process, molecular weights, specific anti-Xa and antiIIa activities, units, dosage and clinical efficacy and safety.
Slovenian: Ta zdravila se med seboj razlikujejo po postopku izdelave, molekulski masi, specifični aktivnosti anti-Xa in anti-IIa, enotah, odmerjanju ter klinični učinkovitosti in varnosti.
English: • When you go home, you may need to continue to use LOVENOX (and associated names) and give it yourself (see instructions below on how to do this).
Slovenian: • Ko boste odšli domov, boste morda morali še naprej uporabljati zdravilo LOVENOX (in povezana imena) in si ga boste morali dajati sami (glejte spodnja navodila, kako to naredite).
English: DATE OF REVISION OF THE TEXT {MM/YYYY} {DD/MM/YYYY} {DD month YYYY}
Slovenian: DATUM ZADNJE REVIZIJE BESEDILA {MM. LLLL} {DD/MM/LLLL} {DD. mesec LLLL}
English: These anticoagulant activities are mediated through anti-thrombin III (ATIII) resulting in antithrombotic activities in humans.
Slovenian: Te antikoagulantne učinke posreduje antitrombin III (ATIII); posledica je antitrombotično delovanje pri človeku.
English: Operations and Anaesthetics
Slovenian: Operacije in anestezija
English: If you forget to use LOVENOX (and associated names) If you forget to give yourself a dose, have it as soon as you remember.
Slovenian: Če ste pozabili uporabiti zdravilo LOVENOX (in povezana imena) Če si pozabite dati odmerek, ga morate dati, čim se spomnite.
English: Stop using LOVENOX (and associated names) and talk to a doctor or nurse at once if you get any signs of a severe allergic reaction (such as difficulty breathing, swelling of the lips, mouth, throat or eyes).
Slovenian: Nehajte uporabljati zdravilo LOVENOX (in povezana imena) in se takoj posvetujte z zdravnikom ali medicinsko sestro, če se vam pojavi kakršen koli znak hude alergijske reakcije (na primer težko dihanje, oteklost ustnic, ust, žrela ali oči).
English: It should not be mixed or coadministered with other medications.
Slovenian: Ne smete ga mešati ali uporabiti sočasno z drugimi zdravili.
English: The 3,000 IU (30 mg) dose can then be directly injected into the IV line.
Slovenian: 3.000 i.e. (30 mg) lahko potem neposredno injicirate v intravensko linijo.
English: Do not give yourself a double dose on the same day to make up for a forgotten dose.
Slovenian: Ne dajte si na en dan dvojnega odmerka,
English: This difference persisted at three months [13.8% vs 5.5% (n=23 vs 9), p=0.01].
Slovenian: Ta razlika se je ohranila tudi po treh mesecih [13,8 % v primerjavi s 5,5 % (n = 23 v primerjavi z 9), p = 0,01].
English: Like other similar medicines (medicines to reduce blood clotting), LOVENOX (and associated names) may cause bleeding which may potentially be life-threatening.
Slovenian: Tako kot druga podobna zdravila (zdravila proti strjevanju krvi) lahko tudi zdravilo LOVENOX (in povezana imena) povzroči krvavitve, ki so lahko celo smrtno nevarne.
English: Multiple Dose Vials:
Slovenian: Večodmerne viale:
English: The absolute bioavailability of enoxaparin sodium after SC injection, based on anti-Xa activity, is close to 100%.
Slovenian: Absolutna biološka uporabnost natrijevega enoksaparinata po subkutani injekciji je na podlagi aktivnosti anti-Xa skoraj 100 %.
English: • Rare: Cutaneous vasculitis*, skin necrosis* usually occurring at the injection site (these phenomena have been usually preceded by purpura or erythematous plaques, infiltrated and painful).
Slovenian: • Redki: Alopecija* • Redki: Kožni vaskulitis*, nekroza kože*, ki se po navadi pojavi na mestu injiciranja (pred temi pojavi so se po navadi razvili purpura ali infiltrirani in boleči eritematozni plaki).
English: Stopping blood clots forming in your blood in the following situations:
Slovenian: Ustavitev nastajanja krvnih strdkov v krvi v naslednjih okoliščinah:
English: Withdraw 30 mL from the infusion bag with a syringe and discard the liquid.
Slovenian: Iz infuzijske vrečke z brizgo odvzemite 30 ml in to tekočino zavrzite.
English: It is important for you to keep having LOVENOX (and associated names) injections until your doctor decides to stop them.
Slovenian: Pomembno je, da injekcije zdravila LOVENOX (in povezana imena) uporabljate, dokler vam zdravnik ne naroči, da prenehajte.
English: Important information about some of the ingredients of LOVENOX (and associated names) LOVENOX (and associated names) contains benzyl alcohol [benzyl alcohol content to be completed nationally].
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila LOVENOX (in povezana imena) Zdravilo LOVENOX (in povezana imena) vsebuje benzilalkohol [vsebnost benzilalkohola dopolni država članica].
English: If you stop using LOVENOX (and associated names) If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.
Slovenian: Če ste prenehali uporabljati zdravilo LOVENOX (in povezana imena) Če imate kakšna dodatna vprašanja o uporabi tega zdravila, se obrnite na zdravnika, farmacevta ali medicinsko sestro.
English: As benzyl alcohol may cross the placenta, it is recommended to use a formulation that does not contain benzyl alcohol.
Slovenian: Benzilalkohol lahko prehaja skozi placento, zato je priporočljivo uporabiti obliko zdravila, ki ne vsebuje benzilalkohola.
English: Do not start treatment with LOVENOX (and associated names) until 12 hours after the final dose of direct oral anticoagulant.
Slovenian: Zdravljenja z zdravilom LOVENOX (in povezana imena) ne začnite prej kot 12 ur po zadnjem odmerku neposrednega peroralnega antikoagulansa.
English: Should thrombocytopenia occur, it usually appears between the 5th and the 21st day following the beginning of enoxaparin sodium treatment.
Slovenian: Če se trombocitopenija pojavi, se to po navadi zgodi med 5. in 21. dnem po začetku zdravljenja z natrijevim enoksaparinatom.
English: • An initial dose of 3,000 IU (30 mg) of LOVENOX (and associated names) will be given as injection into your vein.
Slovenian: • Začetni odmerek 3.000 i.e. (30 mg) zdravila LOVENOX (in povezana imena) boste dobili kot injekcijo v veno.
English: LOVENOX (and associated names) contains benzyl alcohol and must not be used in newborn and premature neonates (see section 4.3).
Slovenian: Zdravilo LOVENOX (in povezana imena) vsebuje benzilalkohol, zato se ga ne sme uporabljati pri novorojenčkih in nedonošenčkih (glejte poglavje 4.3).
English: The amount of LOVENOX (and associated names) given to you will depend on your age and the kind of heart attack you have had.
Slovenian: Količina zdravila LOVENOX (in povezana imena), ki jo boste dobili, bo odvisna od vaše starosti in od vrste srčnega infarkta, ki sta jo imeli.
English: • If you have problems with your kidneys you may be given a smaller amount of LOVENOX (and associated names).
Slovenian: • Če imate težave z ledvicami, boste lahko dobili manjšo količino zdravila LOVENOX (in povezana imena).
English: In order to assure the accuracy of the small volume to be injected, it is recommended to dilute the drug to 300 IU/mL (3 mg/mL).
Slovenian: Da bi zagotovili točnost majhnih injiciranih količin, je zdravilo priporočljivo razredčiti na 300 i.e./ml
English: • Rare: Anaphylactic/Anaphylactoid reactions including shock*
Slovenian: • Redki: Anafilaktične/anafilaktoidne reakcije, vključno s šokom* Bolezni živčevja
English: In surgical patients, haemorrhage complications were considered major: (1) if the haemorrhage caused a significant clinical event, or (2) if accompanied by a haemoglobin decrease ≥ 2 g/dL or transfusion of 2 or more units of blood products.
Slovenian: Pri kirurških bolnikih so bili krvavitveni zapleti ocenjeni kot hudi: (1) če je krvavitev povzročila pomemben kliničen dogodek, ali (2) če jo je spremljalo znižanje hemoglobina za ≥ 2 g/dl ali transfuzija 2 ali več enot krvnih pripravkov.
English: The administration of medicinal product containing benzyl alcohol as a preservative to neonates has been associated with a fatal “Gasping Syndrome” (see section 4.3).
Slovenian: Uporaba zdravil, ki kot konzervans vsebujejo benzilalkohol, je bila pri novorojenčkih povezana s "sindromom hlastajočega dihanja" s smrtnim izidom (glejte poglavje 4.3).
English: • If you have restricted mobility due to illness, you will normally be given 4,000 IU (40 mg) of LOVENOX (and associated names) each day.
Slovenian: • Če imate zaradi bolezni omejeno mobilnost, boste po navadi dobili 4.000 i.e. (40 mg) zdravila LOVENOX (in povezana imena) na dan.
English: The safety and efficacy of LOVENOX (and associated names) has not been evaluated in children or adolescents.
Slovenian: Varnost in učinkovitost zdravila LOVENOX (in povezana imena) pri otrocih in mladostnikih nista bili ocenjeni.
English: • Haemorrhage As with other anticoagulants, bleeding may occur at any site.
Slovenian: Tako kot pri drugih antikoagulansih se lahko kjer koli v telesu pojavi krvavitev.
English: • you are going to receive spinal or epidural anesthesia or lumbar puncture (see Operations and Anaesthetics): a delay should be respected between Lovenox use and this procedure.
Slovenian: • če boste prejeli spinalno ali epiduralno anestezijo ali lumbalno punkcijo (glejte Operacije in anestezija): upoštevati je treba zakasnitev med uporabo zdravila Lovenox in tem postopkom.
English: In case of self-administration, patient should be advised to follow instructions provided in the patient information leaflet included in the pack of this medicine.
Slovenian: V primeru samoinjiciranja je treba bolniku naročiti, naj upošteva navodila v navodilu za uporabo,
English: • IV (bolus) injection (for acute STEMI indication only):
Slovenian: • Intravensko (bolusno) injiciranje (samo za indikacijo akutni STEMI):
English: • Stop blood clots forming in the tubes of your dialysis machine (used for people with severe kidney problems).
Slovenian: • Preprečitev nastajanja krvnih strdkov v cevkah dializne naprave (uporablja se pri osebah, ki imajo hude težave z ledvicami).
English: enoxaparin sodium
Slovenian: natrijev enoksaparinat
English: For patients have an operation called percutaneous coronary intervention (PCI): Depending on when you were last given LOVENOX (and associated names), your doctor may decide to give an additional dose of LOVENOX (and associated names) before a PCI operation.
Slovenian: Pri bolnikih, ki so jim opravili poseg, imenovan perkutana koronarna intervencija (PKI): Odvisno od tega, kdaj ste nazadnje dobili zdravilo LOVENOX (in povezana imena), se zdravnik lahko odloči za dodaten odmerek zdravila LOVENOX (in povezana imena) pred PKI.
English: IV (Bolus) Injection (for acute STEMI indication only):
Slovenian: Intravensko (bolusno) injiciranje (samo za indikacijo akutni STEMI):
English: It must not be used in premature babies or babies up to 1 month old due to the risk risk of severe toxicity including abnormal respiration.
Slovenian: Pri nedonošenčkih in dojenčkih do 1 meseca starosti se ga ne sme uporabljati, ker obstaja tveganje za hude toksične učinke, vključno z nenormalnim dihanjem.
English: • If you have had a reaction to heparin that caused a severe drop in the number of your clotting cells (platelets) - this reaction is called heparin-induced thrombocytopeniawithin the last 100 days or if you have antibodies against enoxaparin in your blood.
Slovenian: • Če ste imeli v zadnjih 100 dneh reakcijo na heparin, ki je povzročila hudo zmanjšanje števila trombocitov (krvnih ploščic) - takšno reakcijo imenujemo s heparinom izzvana trombocitopenija - ali če imate v krvi protitelesa proti enoksaparinu.
English: If the combination is indicated, enoxaparin sodium should be used with careful clinical and laboratory monitoring when appropriate.
Slovenian: Če je kombinirano zdravljenje indicirano, je priporočljivo natrijev enoksaparinat uporabljati ob natančnem kliničnem in laboratorijskem nadzoru,
English: • Because of the content of benzyl alcohol (see section 6.1), enoxaparin sodium multiple dose vial formulation must not be given to newborns or premature neonates (see sections 4.4 and 4.6).
Slovenian: • Zaradi vsebnosti benzilalkohola (glejte poglavje 6.1) se natrijevega enoksaparinata iz večodmernih vial ne sme dajati novorojenčkom ali nedonošenčkom (glejte poglavji 4.4 in 4.6).
English: Investigations • Rare: Hyperkalaemia* (see sections 4.4 and 4.5)
Slovenian: Preiskave • Redki: Hiperkaliemija* (glejte poglavji 4.4 in 4.5)
English: • Common: Injection site haematoma, injection site pain, other injection site reaction (such as oedema, haemorrhage, hypersensitivity, inflammation, mass, pain, or reaction)
Slovenian: • Pogosti: Hematom na mestu injiciranja, bolečina na mestu injiciranja, druge reakcije na mestu injiciranja (na primer edem, krvavitev, preobčutljivost, vnetje, masa, bolečina ali reakcija)
English: LOVENOX (and associated names) works in two ways.
Slovenian: Zdravilo LOVENOX (in povezana imena) deluje na dva načina.
English: Benzyl alcohol may also cause toxic reactions and anaphylactoid reactions in infants and children up to 3 years old (see section 4.4).
Slovenian: Benzilalkohol lahko pri dojenčkih in otrocih do 3. leta starosti povzroči tudi toksične in anafilaktoidne reakcije (glejte poglavje 4.4).
English: It is recommended to use the LOVENOX formulation without benzyl alcohol in pregnant women.
Slovenian: Pri nosečnicah je priporočljivo uporabljati obliko zdravila LOVENOX brez benzilalkohola.